Filing Details
- Accession Number:
- 0001209191-21-070206
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-17 15:29:23
- Reporting Period:
- 2021-12-17
- Accepted Time:
- 2021-12-17 15:29:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1160308 | Savara Inc | SVRA | Pharmaceutical Preparations (2834) | 841318182 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1408498 | L David Lowrance | 6836 Bee Cave Road Building Iii, Suite 201 Austin TX 787846 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-12-17 | 4,000 | $1.14 | 142,793 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price is a weighted average purchase price. The purchase prices ranged from $1.12 to $1.15. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
Billionaire Hedge Funds
